IIntegra Therapeutics — Seed · €6M
Integra Tx is a Pompeu Fabra University spin-off developing next-generation gene-writing tools. It closed a €4.5M first round led by Advent France Biotechnology with Invivo Capital and Takeda Ventures, to complete its prototype and run preclinical validation in 2022-2023.
LeadAdvent France Biotechnology
RoundSeed
Announced2 Dec 2021
CityBarcelona
SectorHealthtech & Bio · Biotech / Gene editing
Source
E
Extended 29 Mar 2022: +€1.5M from Columbus Venture Partners
The company
Investors 5
A
Advent France Biotechnology
AAdBio Partners (formerly Advent France Biotechnology)
CColumbus Venture Partners
columbusvp.com
I
Invivo Capital
invivocapital.com
TTakeda Ventures